Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year revenue growth rate
Latest
25.32%
Near historical average
Average (30q)
23.49%
Historical baseline
Range
High:283.05%
Low:-3.86%
Volatility
1221.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 25.32% |
| Q2 2025 | 38.51% |
| Q1 2025 | -3.86% |
| Q4 2024 | 81.41% |
| Q3 2024 | 123.27% |
| Q2 2024 | 283.05% |
| Q1 2024 | 180.35% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |